LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway. - Zhou SZ; Li H; Wang ZW; Wang MH; Li N; Wang YF (Cell cycle (Georgetown, Tex.), 2020)